SARAH-ELIZABETH SEWAK NICHOLS: Open Payments
NPI 1366957896 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 45 payments from 10 companies in 2025. Trend: 2023 $621 · 2024 $1,168 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $217 |
| Galderma Laboratories, L.P. | 11 | $186 |
| Lilly USA, LLC | 4 | $92 |
| GENZYME CORPORATION | 1 | $92 |
| PFIZER INC. | 5 | $82 |
| ABBVIE INC. | 3 | $66 |
| UCB, Inc. | 1 | $41 |
| Organon LLC | 2 | $36 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
| Incyte Corporation | 1 | $20 |
Products named: NEMLUVIO, COSENTYX, DUPIXENT, CIBINQO, EBGLYSS, SKYRIZI, Bimzelx, Zoryve.
Industry payments across AL — which companies pay providers there.
